Avicanna Inc. (AVCN.TO) experienced a notable decline in its stock price this week, despite recent developments in the healthcare sector.
Avicanna Inc. has had a tough week, with its stock closing down 8.33% on Friday. The company, which operates in the healthcare sector, has been in the news for its recent efforts to integrate medical cannabis into Canadian healthcare. However, the market has reacted cautiously, reflecting a broader sentiment among investors.
Investor takeaway: Investors should consider the implications of Avicanna's recent initiatives and market performance, particularly in light of its strategic goals and current financial standing.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.78M
52W high
$0.30
52W low
$0.10
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 536.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+536.4% Upside
Current Price
C$0.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
95.6%
Annualized
90-Day Vol
81.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.14 |
| 60 trading days | C$0.10 | C$0.06 – C$0.16 |
| 90 trading days | C$0.09 | C$0.05 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avicanna's Stock Down 8.33% This Week, Year-to-Date Decline at 50%
The stock's price has fallen to C$0.10, significantly below its 50-day and 200-day moving averages, indicating a challenging technical landscape.
Bull case
The launch of the MyMedi.ca Integrated Healthcare Program and participation in investor forums may increase Avicanna's visibility and credibility in the healthcare space. This could potentially attract more investors and partnerships.
Bear case
Despite these positive initiatives, the stock continues to face significant downward pressure, with a year-to-date decline of 50%. The company is also dealing with negative profit margins and high implied volatility, which may deter cautious investors.
Recent Price Action
Advertisement
Avicanna Inc. (AVCN.TO) saw its stock price drop by 8.33% on Friday, closing at C$0.10. Over the past week, the stock has remained unchanged, while it has experienced a 15.38% decline over the past month. Year-to-date, the stock is down a staggering 50%, indicating significant challenges for the company.
Company News and Initiatives
Despite the downturn in stock performance, Avicanna has been active in the healthcare sector. Recently, the company announced its participation in a Life Sciences Investor Forum scheduled for September 17, 2026. Additionally, on September 9, 2026, Avicanna launched the MyMedi.ca Integrated Healthcare Program, which aims to incorporate medical cannabis care into Canadian healthcare institutions and clinical networks. These initiatives could enhance the company's profile and attract further investment.
Technical Picture
From a technical standpoint, Avicanna's stock is currently trading below both its 50-day moving average of C$0.13 and its 200-day moving average of C$0.16, reflecting a bearish trend. The stock's 52-week range is between C$0.10 and C$0.30, indicating it is currently at the lower end of this range. With a beta of 0.34, the stock is considered less volatile compared to the broader market. The latest trading volume was 91,000 shares, which is notably lower than the 20-day average of 151,172 shares, indicating reduced investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
